NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 20 04:00PM ET
24.38
Dollar change
-0.70
Percentage change
-2.79
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-10.40% Shs Outstand Perf Week-6.80%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings51 Perf Month1.18%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM69.59M Perf Quarter-3.08%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y-3.96%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf YTD0.30%
Active/Passive Quant Type Tags- Flows% 1M3.95% 52W Range20.10 - 29.85 Perf Year-9.64%
Dividend TTM0.50 (2.05%) ESG Type Tags- Flows% 3M6.92% 52W High-18.34% Beta1.00
Dividend Ex-DateDec 11, 2024 Dividend Type Sector/Theme Flows% YTD48.10% 52W Low21.32% ATR (14)0.62
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y RSI (14)46.83 Volatility1.79% 1.91%
Expense0.75% Growth/Value SMA20-1.85% Flows% 3Y Rel Volume0.98 Prev Close25.08
Inverse/Leveraged Market Cap SMA501.15% Flows% 5Y Avg Volume8.79K Price24.38
IPOAug 16, 2023 Option/ShortNo / Yes SMA200-5.25% Trades Volume8,588 Change-2.79%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.